Next Article in Journal
Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics
Previous Article in Journal
Mechanisms of Entry and Endosomal Pathway of African Swine Fever Virus
Article Menu

Export Article

Open AccessLetter
Vaccines 2017, 5(4), 43;

A New Whooping Cough Vaccine That May Prevent Colonization and Transmission

Aeras, 1405 Research Blvd., Rockville, MD 20850, USA
Iliad Biotechnologies, 230 East 15th Street, Suite 1-A, New York, NY 10003, USA
Academic Editor: Toshi Nagata
Received: 8 October 2017 / Revised: 2 November 2017 / Accepted: 6 November 2017 / Published: 10 November 2017
Full-Text   |   PDF [148 KB, uploaded 10 November 2017]


This article is a Letter to the Editor. The major purpose of this Letter is to highlight the development of a new genetically altered whooping cough vaccine. Recently a baboon model has been used to show that this next generation pertussis vaccine can prevent colonization, as well as disease, and elicit antibodies against major pertussis antigens. Two phase I clinical trials have been performed, showing that this new vaccine is safe in humans, and a phase II trial will be performed in the US in 2018. View Full-Text
Keywords: Bordetella pertussis; whooping cough vaccine; BPZE1 Bordetella pertussis; whooping cough vaccine; BPZE1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Brennan, M.J. A New Whooping Cough Vaccine That May Prevent Colonization and Transmission. Vaccines 2017, 5, 43.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top